Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly (butyl cyanoacrylate) nanoparticles
J Duan, HM Mansour, Y Zhang, X Deng, Y Chen… - International journal of …, 2012 - Elsevier
Co-encapsulated doxorubicin (DOX) and curcumin (CUR) in poly (butyl cyanoacrylate)
nanoparticles (PBCA-NPs) were prepared with emulsion polymerization and interfacial …
nanoparticles (PBCA-NPs) were prepared with emulsion polymerization and interfacial …
Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles
CE Soma, C Dubernet, D Bentolila, S Benita… - Biomaterials, 2000 - Elsevier
Individual and combined polyalkylcyanoacrylate nanoparticle formulation of cyclosporin A
and doxorubicin were prepared and evaluated in an attempt to show improved growth …
and doxorubicin were prepared and evaluated in an attempt to show improved growth …
Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer
S Tang, Q Yin, Z Zhang, W Gu, L Chen, H Yu, Y Huang… - Biomaterials, 2014 - Elsevier
An appropriate co-delivery system for chemotherapeutic agents and nucleic acid drugs will
provide a more efficacious approach for the treatment of breast cancer by reversing …
provide a more efficacious approach for the treatment of breast cancer by reversing …
Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer
Q Wang, C Zou, L Wang, X Gao, J Wu, S Tan, G Wu - Acta Biomaterialia, 2019 - Elsevier
Multi-drug resistance (MDR) of tumor is a major cause of chemotherapy failure. In this study,
a pH-sensitive graft copolymer, poly (β-amino ester)-g-β-cyclodextrin (PBAE-g-β-CD), was …
a pH-sensitive graft copolymer, poly (β-amino ester)-g-β-cyclodextrin (PBAE-g-β-CD), was …
Amphiphilic copolymeric micelles for doxorubicin and curcumin co-delivery to reverse multidrug resistance in breast cancer
LI Lv, K Qiu, X Yu, C Chen, F Qin, Y Shi… - Journal of …, 2016 - ingentaconnect.com
Development of multidrug resistance against chemotherapeutic drugs is one of the major
obstacles to successful cancer therapy in the clinic. Thus far, amphiphilic polymeric micelles …
obstacles to successful cancer therapy in the clinic. Thus far, amphiphilic polymeric micelles …
Co-delivery nanoparticles of doxorubicin and chloroquine for improving the anti-cancer effect in vitro
JH Sun, C Ye, EH Bai, LL Zhang, SJ Huo, HH Yu… - …, 2018 - iopscience.iop.org
To increase the efficacy of small molecule chemotherapeutic drug (SMCD) and reduce its
toxic and side effects, we selected two model drugs doxorubicin (DOX) and chloroquine …
toxic and side effects, we selected two model drugs doxorubicin (DOX) and chloroquine …
Phenylboronic acid-conjugated chitosan nanoparticles for high loading and efficient delivery of curcumin
J Wang, LG Liu, WQ Jiao, H Yang, J Liu, D Liu - Carbohydrate Polymers, 2021 - Elsevier
In order to achieve high loading and efficient delivery of curcumin, phenylboronic acid-
conjugated chitosan nanoparticles were prepared by a simple desolvation method. These …
conjugated chitosan nanoparticles were prepared by a simple desolvation method. These …
Synthesis and in vitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems
R Hu, H Zheng, J Cao, Z Davoudi… - Journal of biomedical …, 2017 - ingentaconnect.com
Compared to the conventional anti-cancer drugs, the nano-drug delivery systems (NDDS)
shows a comparatively ideal therapeutic efficacy ascribing their high tumor-target capacity …
shows a comparatively ideal therapeutic efficacy ascribing their high tumor-target capacity …
Co-delivery of curcumin and paclitaxel by “core-shell” targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer
MD Zhao, JQ Li, FY Chen, W Dong… - International journal …, 2019 - Taylor & Francis
Background Ovarian cancer is a common malignancy in the female reproductive system with
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …
Reversion of multidrug resistance by co-encapsulation of doxorubicin and metformin in poly (lactide-co-glycolide)-d-α-tocopheryl polyethylene glycol 1000 succinate …
V Shafiei-Irannejad, N Samadi, R Salehi… - Pharmaceutical …, 2018 - Springer
Purpose P-glycoprotein (P-gp) mediated multidrug resistance (MDR) has been recognized
as the main obstacle against successful cancer treatment. To address this problem, co …
as the main obstacle against successful cancer treatment. To address this problem, co …
相关搜索
- breast cancer multidrug resistance
- butyl cyanoacrylate doxorubicin and curcumin
- doxorubicin and curcumin multidrug resistance
- butyl cyanoacrylate multidrug resistance
- doxorubicin and curcumin chitosan poly
- butyl cyanoacrylate chitosan poly
- chitosan poly multidrug resistance
- succinate nanoparticles multidrug resistance
- curcumin analog drug carrier
- chitosan nanoparticles high loading
- chitosan nanoparticles efficient delivery
- α tocopheryl multidrug resistance
- polyethylene glycol multidrug resistance
- polyalkylcyanoacrylate nanoparticles multidrug resistance